<--- Back to Details
First PageDocument Content
Rare diseases / Augie Nieto / Amyotrophic lateral sclerosis / James Heywood / Sean F. Scott / ALS Therapy Development Institute / Health / Motor neurone disease
Date: 2009-05-07 10:16:35
Rare diseases
Augie Nieto
Amyotrophic lateral sclerosis
James Heywood
Sean F. Scott
ALS Therapy Development Institute
Health
Motor neurone disease

Microsoft Word - Perrin Appointment[removed]final.doc

Add to Reading List

Source URL: www.als.net

Download Document from Source Website

File Size: 78,79 KB

Share Document on Facebook

Similar Documents

Amyotrophic lateral sclerosis / Neurology / Health / Nervous system / ALS Therapy Development Institute / ALS / Sean F. Scott / James Heywood

Microsoft Word - Neurotune Final PR - 051412_Logo.docx

DocID: 1qt11 - View Document

Genomics / Statistical genetics / Classical genetics / Genetic mapping / Human genome / Genetic linkage / Quantitative trait locus / Contig / Genome / Biology / Genetics / Philosophy of biology

Extension of PigQTLdb: Genome-wide Alignment of BAC FPC Maps and RH Maps for QTL Positional Gene Mining Zhi-liang Hu 1, Sean Humphray 2, Carol Scott 2, Stacey N. Meyers 3, Jane Rogers 2, Max F. Rothschild 1 and James M.

DocID: 19R4p - View Document

Motor neurone disease / Augie Nieto / Amyotrophic lateral sclerosis / Sean F. Scott / James Heywood / Rare diseases / ALS Therapy Development Institute / Health

flatIconSet- [Converted].eps

DocID: IJsD - View Document

Health / Amyotrophic lateral sclerosis / Neuroscience / Sean F. Scott / James Heywood / ALS Therapy Development Institute / Rare diseases / Motor neurone disease

The ALS Therapy Development Institute Partners with Regenesance BV to Investigate Potential Treatments for Lou Gehrig’s Disease Complement Pathway Modulation at Center of Collaboration May 7, [removed]CAMBRIDGE & AMSTERD

DocID: GyZb - View Document

Health / Amyotrophic lateral sclerosis / SOD1 / Neuroscience / Sean F. Scott / James Heywood / ALS Therapy Development Institute / Motor neurone disease / Rare diseases

ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS

DocID: GxZa - View Document